Rare lephants
Screener

Gyre Therapeutics, Inc.

GYRE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 6, 2025 FORM 4
4 Jun 6, 2025 FORM 4
4 Jun 6, 2025 FORM 4
4 Jun 6, 2025 FORM 4
8-K Jun 6, 2025 8-K
4 May 29, 2025 FORM 4
4 May 28, 2025 FORM 4
4 May 27, 2025 FORM 4
8-K May 23, 2025 8-K
424B5 May 23, 2025 424B5
424B5 May 22, 2025 424B5
8-K May 22, 2025 8-K
4 May 22, 2025 FORM 4
4 May 20, 2025 FORM 4
4 May 16, 2025 FORM 4
4 May 14, 2025 FORM 4
4 May 14, 2025 FORM 4
10-Q May 9, 2025 10-Q
8-K May 9, 2025 8-K
8-K Apr 28, 2025 8-K
4 Apr 25, 2025 FORM 4
ARS Apr 22, 2025 ARS
DEFA14A Apr 21, 2025 DEFA14A
DEF 14A Apr 21, 2025 DEF 14A
4 Apr 18, 2025 FORM 4
← Newer Page 4 of 65 · 1601 filings Older →